Leitlinie „Behandlung der Akne“ - AWMF

013/017 - Behandlung der Akne aktueller Stand: 02/2010
korrigierte Fassung: 10/2011
221. Gollnick H. Die C9-Dicarbonsäure Azelainsäure als neue Substanz im Spektrum der
Akne-Therapeutika. Dermatol Monatsschr. 1992; 178: 143-52.
222. Shibata M, Katsuyama M, Onodera T, Ehama R, Hosoi J, Tagami H. Glucocorticoids
enhance Toll-like receptor 2 expression in human keratinocytes stimulated with
Propionibacterium acnes or proinflammatory cytokines. J Invest Dermatol. 2009; 129:
375-82.
223. Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated with the cosmetic
use of bleaching products in women from Dakar, Senegal. Br J Dermatol. 2003; 148:
493-500.
224. Nnoruka E, Okoye O. Topical steroid abuse: its use as a depigmenting agent. J Natl
Med Assoc. 2006; 98: 934-9.
225. Callender VD. Considerations for treating acne in ethnic skin. Cutis. 2005; 76: 19-23.
226. Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris:
efficacy and safety. Arch Dermatol. 1975; 111: 1630-6.
227. Lehmann HP, Andrews JS. Management of Acne (Evidence Report/Technology
Assessment No. 17 (Prepared by John Hopkins Evidence-based Practice Center under
Contract No. 290-97-006). Rockville, MD: Agency for Healthcare Research and
Quality, 2001.
228. Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris:
efficacy and safety. Cochrane Database Syst Rev. 2003: CD002086.
229. Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman SN. Acne therapy:
a methodologic review. J Am Acad Dermatol. 2002; 47: 231-40.
230. Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H. European
recommendations on the use of oral antibiotics for acne. Eur J Dermatol. 2004; 14:
391-9.
231. Ochsendorf F. Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges.
2006; 4: 828-41.
232. Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment
of acne vulgaris: a review. Br J Dermatol. 2008; 158: 208-16.
233. Campo M, Zuluaga A. A comparative study on the effectiveness of lymecicline and
adapalene versus minocicline and adapalene in the treatment of acne vulgaris.
Proceedings 20th World Congress of Dermatology. Paris, France, 2002.
234. Mobacken H. [Oral tetracycline--treatment of acne. Rapid facial improvement, but
back lesions are more difficult to treat]. Lakartidningen. 1993; 90: 2755-7.
235. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack
J. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris:
a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol. 2006;
142: 605-12.
236. Pierard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P,
Pierard GE. Lymecycline and minocycline in inflammatory acne: a randomized,
double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy. Skin
Pharmacol Appl Skin Physiol. 2002; 15: 112-9.
Seite 120 von 136